# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Citigroup analyst Joanna Wiensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $128 t...
Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings.
- Reuters
More than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment o...